Breast magnetic resonance imaging alters patient selection for accelerated partial breast irradiation

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 37, Issue 3, 2014, Pages 248-254

  Horst, Kathleen C ^a   Ikeda, Debra M ^a   Fero, Katherine E ^a   Daniel, Bruce L ^a   Goffinet, Don R ^a   Dirbas, Frederick M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

3 dimensional conformal external beam radiotherapy (3DCRT); Accelerated partial breast irradiation (APBI); Breast cancer; Breast magnetic resonance imaging (MRI); Intraoperative radiotherapy (IORT)

Indexed keywords

ACCELERATED PARTIAL BREAST IRRADIATION; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; COHORT ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; CONTRAST ENHANCEMENT; ECHOMAMMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INTRAOPERATIVE RADIOTHERAPY; INVASIVE CARCINOMA; IRRADIATION; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARTIAL MASTECTOMY; PATIENT SELECTION; PHYSICAL EXAMINATION; THREE DIMENSIONAL IMAGING; BREAST TUMOR; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; IMAGE GUIDED BIOPSY; INTRAOPERATIVE PERIOD; LABORATORY DIAGNOSIS; MASTECTOMY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RADIATION DOSE FRACTIONATION; SEGMENTAL MASTECTOMY; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DOSE FRACTIONATION; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMAGE-GUIDED BIOPSY; INTRAOPERATIVE PERIOD; MAGNETIC RESONANCE IMAGING; MASTECTOMY, MODIFIED RADICAL; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME; ULTRASONOGRAPHY, MAMMARY;

EID: 84908024350     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e318277d7c8     Document Type: Article

References (55)

1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
2. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227-1232.
3. van Dongen J, Voogd A, Fentiman I, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000;92:1143-1150.
4. Arriagada R, Le M, Rochard F, et al. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol. 1996;14:1558-1564.
5. Jacobson J, Danforth D, Cowan K, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 1995;332:907-911.
6. Blichert-Toft M, Rose C, Andersen J, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr. 1992;19-25.
7. Liljegren G, Holmberg L, Bergh J, et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J Clin Oncol. 1999; 17:2326-2333.
8. Clark R, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: An update. Ontario Clinical Oncology Group. J Natl Cancer Inst. 1996;88:1659-1664.
9. Kemperman H, Borger J, Hart A, et al. Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence. Eur J Cancer. 1995;31A: 690-698.
10. Veronesi U, Marubini E, Del Vecchio M, et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst. 1995;87:19-27.
11. Fisher B, Anderson S, Fisher E, et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet. 1991; 338:327-331.
12. Fortin ALM, Laverdiere J, Lavertu S, et al. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol. 1999;17:101-109.
13. Wapnir IL, Anderson SJ, Mamounas EP, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol. 2006;24: 2028-2037.
14. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;366:2087-2106.
15. Vicini FABK, Kestin LL, et al. Accelerated treatment of breast cancer. J Clin Oncol. 2001;19:1993-2001.
16. Ribeiro G, Dunn G, Swindell R, et al. Conservation of the breast using two different radiotherapy techniques: Interim report of a clinical trial. Clin Oncol (R Coll Radiol). 1990;2:27-34.
17. Fentiman I, Poole C, Tong D, et al. Iridium implant treatment without external radiotherapy for operable breast cancer: A pilot study. Eur J Cancer. 1991;27:447-450.
18. Arthur DW, Vicini FA, Kuske RR, et al. Accelerated partial breast irradiation: An updated report from the American Brachytherapy Society. Brachytherapy. 2002;1:184-190.
19. Polgar C, Fodor J, Orosz Z, et al. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial. Strahlenther Onkol. 2002;178:615-623.
20. Orecchia R, Ciocca M, Lazzari R, et al. Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancer. Breast. 2003;12:483-490.
21. NSABP B-39, RTOG 0413: A Randomized Phase III Study of conventional whole breast irradiation versus partial breast irradiation for women with stage 0, I, or II breast cancer. Clin Adv Hematol Oncol. 2006;4:719-721.
22. Hata T, Takahashi H, Watanabe K, et al. Magnetic resonance imaging for preoperative evaluation of breast cancer: A comparative study with mammography and ultrasonography. J Am Coll Surg. 2004;198:190-197.
23. Boetes C, Mus RD, Holland R, et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology. 1995;197:743-747.
24. Sardanelli F, Giuseppetti GM, Panizza P, et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol. 2004;183:1149-1157.
25. Esserman L, Hylton N, Yassa L, et al. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol. 1999;17:110-119.
26. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of Magnetic Resonance Imaging and Mammography for Breast Cancer Screening in Women With a Familial or Genetic Predisposition. Obstet Gynecol Surv. 2005;60:107-109.
27. Olson JA Jr, Morris EA, Van Zee KJ, et al. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol. 2000;7:411-415.
28. Agoston AT, Daniel BL, Herfkens RJ, et al. Intensity-modulated parametric mapping for simultaneous display of rapid dynamic and high-spatial-resolution breast MR imaging data. Radiographics. 2001;21:217-226.
29. Daniel BL, Yen YF, Glover GH, et al. Breast disease: dynamic spiral MR imaging. Radiology. 1998;209:499-509.
30. Leong CS, Daniel BL, Herfkens RJ, et al. Characterization of breast lesion morphology with delayed 3DSSMT: An adjunct to dynamic breast MRI. J Magn Reson Imaging. 2000;11:87-96.
31. Ikeda DM, Hylton NM, Kuhl CK, et al. BI-RADS: Magnetic Resonance Imaging. In: D'Orsi CJ, Mendelson EB, Ikeda DM, et al. Breast Imaging Reporting and Data System: ACR BIRADS- Breast Imaging Atlas, 1st ed. Reston, VA: American College of Radiology, 2003.
32. Daniel BLBR, Butts K, et al. Freehand iMRI-guided large-gauge core needle biopsy: A new minimally invasive technique for diagnosis of enhancing breast lesions. J Magn Reson Imaging. 2001;13:896-902.
33. Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74:987-1001.
34. Harris J, Connolly J, Schnitt S, et al. The use of pathologic features in selecting the extent of surgical resection necessary for breast cancer patients treated by primary radiation therapy. Ann Surg. 1985;201:164-169.
35. Connolly J, Boyages J, Nixon A, et al. Predictors of breast recurrence after conservative surgery and radiation therapy for invasive breast cancer. Mod Pathol. 1998;11:134-139.
36. Fisher B, Bryant J, Dignam J, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol. 2002;20:4141-4149.
37. Horst KC, Smitt MC, Goffinet DR, et al. Predictors of local recurrence after breast-conservation therapy. Clin Breast Cancer. 2005;5:425-438.
38. Rosen P, Fracchia A, Urban J, et al. "Residual" mammary carcinoma following simulated partial mastectomy. Cancer. 1975;35:739-747.
39. Lagios M. Multicentricity of breast carcinoma demonstrated by routine correlated serial subgross and radiographic examination. Cancer. 1977;40:1726-1734.
40. Holland R, Veling S, Mravunac M, et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985;56:979-990.
41. Faverly DR, Hendriks JH, Holland R. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements. Cancer. 2001;91:647-659.
42. Pavic D, Koomen MA, Kuzmiak CM, et al. The role of magnetic resonance imaging in diagnosis and management of breast cancer. Technol Cancer Res Treat. 2004;3:527-541.
43. Hlawatsch A, Teifke A, Schmidt M, et al. Preoperative assessment of breast cancer: Sonography versus MR imaging. AJR Am J Roentgenol. 2002;179:1493-1501.
44. Malur S, Wurdinger S, Moritz A, et al. Comparison of written reports of mammography, sonography and magnetic resonance mammography for preoperative evaluation of breast lesions, with special emphasis on magnetic resonance mammography. Breast Cancer Res. 2001;3:55-60.
45. Schelfout K, Van Goethem M, Kersschot E, et al. Contrastenhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol. 2004;30:501-507.
46. Fischer U, Zachariae O, Baum F, et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol. 2004;14:1725-1731.
47. Langer SA, Horst KC, Ikeda DM, et al. Pathologic correlates of false positive breast magnetic resonance imaging findings: Which lesions warrant biopsy? Am J Surg. 2005;190:633-640.
48. Siegmann KC, Muller-Schimpfle M, Schick F, et al. MR imaging detected breast lesions: Histopathologic correlation of lesion characteristics and signal intensity data. AJR Am J Roentgenol. 2002;178:1403-1409.
49. Liberman LMG, Morris EA, et al. Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size. Am J Roentgenol. 2006;186:426-430.
50. Kuhl CK, Bieling HB, Gieseke J, et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclicalphase dependency. Radiology. 1997;203:137-144.
51. Heinig A, Lampe D, Kolbl H, et al. Suppression of unspecific enhancement on breast magnetic resonance imaging (MRI) by antiestrogen medication. Tumori. 2002;88:215-223.
52. Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology. 1993; 187:493-501.
53. Stomper PC, Herman S, Klippenstein DL, et al. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology. 1995;197:387-395.
54. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology. 1999;213:881-888.
55. Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer. 2003;98: 468-473.